Today: 27 April 2026
Browse Category

SWX:SREN.SW 26 November 2025

Swiss Stock Market Today, 26 November 2025: SMI Edges Higher as Sentiment Surges and Insurers Face Tougher Rules

Swiss Stock Market Today, 26 November 2025: SMI Edges Higher as Sentiment Surges and Insurers Face Tougher Rules

The Swiss Market Index closed up 0.07% at 12,781.09 on Wednesday, its highest in about a week, extending a three-day advance. Turnover topped 2.4 million contracts. Investor sentiment jumped after a thaw in Swiss-US trade tensions. Zurich Insurance, Swiss Re, and Swiss Life drew attention after being added to the G20 Financial Stability Board’s insurer resolution list.
26 November 2025
········

Stock Market Today

  • Wall Street's Fear Gauge VIX Rises Amid S&P 500 Rally, Signal Mixed Market Sentiment
    April 27, 2026, 5:39 PM EDT. The Cboe Volatility Index (VIX), Wall Street's key "fear gauge," has unexpectedly risen alongside the S&P 500 hitting record highs. Typically, the VIX moves inversely to stocks, but this concurrent surge points to mixed investor sentiment. Some traders suspect hedging against geopolitical risks like the Iran war and rising crude oil prices, signaling potential near-term volatility. Alternatively, robust buying of call options, especially in semiconductor and tech stocks leading the rally, inflates options premiums and keeps the VIX elevated. Notably, semiconductor ETF VanEck Semiconductor (SMH) shows 25% higher call premiums than puts. A large bullish bet in Marvell Technology highlights investor appetite for further gains despite recent doubling since earnings. This unusual price dynamic suggests heightened caution amid optimism in the market.

Latest article

3I/ATLAS Comet’s Strange Water Points To A Birthplace Unlike Our Solar System

3I/ATLAS Comet’s Strange Water Points To A Birthplace Unlike Our Solar System

27 April 2026
Astronomers using ALMA have measured deuterated water in interstellar comet 3I/ATLAS, finding a deuterium-to-hydrogen ratio over 40 times higher than Earth’s oceans. The result indicates the comet formed in a much colder environment than the early solar system. The data were collected just after the comet’s perihelion as it now leaves the solar system.
Oruka Therapeutics Stock Surges After Psoriasis Drug Data as Biotech Seeks $500 Million

Oruka Therapeutics Stock Surges After Psoriasis Drug Data as Biotech Seeks $500 Million

27 April 2026
Oruka Therapeutics reported its experimental psoriasis drug ORKA-001 achieved complete skin clearance in 63.5% of patients at 16 weeks. Shares jumped 10.5% to $76.39 before the company launched a $500 million public offering. No serious adverse events were reported in the trial. ORKA-001 is being developed as a long-acting injectable, with annual dosing possible.
Go toTop